Urethral stent system and method

• US 9,622,848 B2
• Filed: 02/23/2012
• Issued: 04/18/2017
• Est. Priority Date: 02/23/2011
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Lund, Jonathan J.
• Primary Examiner(s): KUHLMAN, CATHERINE BURK
• Application Number:
  US13/403,795
• Publication Number:
  US 20120238803A1
• Time in Patent Office: 1,881 Days
• Field of Search: 600 29- 32, 600 37
• CPC Class Codes: A61F 2/0009 placed in or outside the body opening close to the surface of the body plugging an opening in the wall of a hollow or tubular organ A61B17/0057
• CPC Class Codes: A61F 2/04 Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts A61F2/18, A61F2/20 take precedence; devices, other than stent-grafts, providing patency to, or preventing collapsing of, tubular structures of the body other than stent-grafts, e.g. stents A61F2/82; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95
• CPC Class Codes: A61F 2002/047 Urethrae

Abstract

A urethral stent device comprising a mechanical valve system is provided. The urethral stent device can be delivered up through the urethra via a flexible delivery tool. The valve mechanism is adapted to open when exposed to a certain amount of intraluminal pressure and can remain open until a desired cessation of fluid flow is achieved.

Claims

1. A system for treating urinary incontinence in a patient, comprising:

a stent-like device configured for deployment within a urethra, the stent-like device having;

first and second body portions; and

an interior valve mechanism having a pivoting member including a stopper member, a flange member, and a biasing member, the biasing member including a spring member, the biasing member biasing the pivoting member toward a closed position such that urine flow is at least substantially blocked through the valve mechanism to promote continence, with the stopper member defining a first arm structure and the flange member defining a second arm structure extending at a fixed angle from the stopper member such that the stopper member and the flange member are operably connected to rotate together and the distance therebetween does not substantially change, wherein the valve mechanism is configured such that, during normal operation, the valve mechanism is passively actuated toward an open position when a threshold fluid pressure force is applied to the flange member parallel to a natural direction of urine flow through the urethra without application of an external force.

2. The system of claim 1, wherein at least one of the first and second body portions is constructed of a self-expanding mesh material.

3. The system of claim 1, wherein the first and second body portions are constructed of a self-expanding mesh material.

4. The system of claim 1, wherein the stopper member is provided in an initial seat position to seal off a urine flow path through the valve mechanism when urine flow is at least substantially blocked through the valve mechanism.

5. The system of claim 4, wherein the stopper member is pivotable to an unseated position against the bias of the biasing member to permit urine flow along a flow path through the valve mechanism.

6. The system of claim 1, further including an introducer tool having a catheter portion and a handle actuation portion.

7. The system of claim 6, wherein the catheter portion includes a distal end portion adapted to receive the stent-like device.

8. The system of claim 7, wherein the handle actuation portion is actuated to deploy the stent-like device from the distal end portion of the catheter portion.

9. A system for treating urinary incontinence in a patient, comprising:

a stent-like device configured for deployment within a urethra, the stent-like device having;

first and second self-expanding body portions; and

a single interior valve mechanism having a single pivoting flange member, a single pivoting stopper member, and a biasing member, the biasing member biasing the stopper member toward a closed position such that urine flow is at least substantially blocked through the valve mechanism to promote continence, wherein the pivoting stopper member defines an arm structure that extends generally perpendicular from the pivoting flange member such that the pivoting stopper member correspondingly rotates with the pivoting flange member such that the distance between the pivoting stopper member and the pivoting flange member remains substantially constant and does not decrease, wherein the biasing member is positioned at a pivot point around which the pivoting flange member and the pivoting stopper member pivot.

10. The system of claim 9, further including an introducer tool having a catheter portion and an actuation portion.

11. The system of claim 10, wherein the catheter portion includes a distal end portion adapted to receive the stent-like device.

12. The system of claim 11, wherein the actuation portion is actuated to deploy the stent-like device from the distal end portion of the catheter portion.

13. The system of claim 9, wherein the biasing member includes a spring member.

14. A system for treating urinary incontinence in a patient, comprising:

a stent-like device configured for deployment within a urethra, the stent-like device having;

first and second self-expanding body portions; and

an interior valve mechanism having a pivoting flange member, a pivoting stopper member, and a biasing member, the biasing member biasing the stopper member toward a closed position such that urine flow is at least substantially blocked through the valve mechanism to promote continence, wherein the pivoting stopper member defines an arm structure that extends generally perpendicular from the pivoting flange member such that the pivoting stopper member correspondingly rotates with the pivoting flange member such that the distance between the pivoting stopper member and the pivoting flange member remains substantially constant and does not decrease, wherein the biasing member is positioned at a pivot point around which the pivoting flange member and the pivoting stopper member pivot, wherein the stopper member is configured to be pivotable to a second position when a threshold urine flow pressure is exerted on the flange member such that the stopper member is pivoted to an unseated position to permit urine flow along a flow path through the valve mechanism.